ArticleJournal of gastrointestinal oncology2026

Fruquintinib in refractory metastatic colorectal cancer: separating randomized trial evidence from observational data.

George Koulaouzidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.